Dr. Amir Mortazavi
Claim this profileOhio State University Comprehensive Cancer Center
Studies Bladder Cancer
Studies Cancer
8 reported clinical trials
12 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
Stage II
Stage I
2Cancer
Stage IV
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Amir Mortazavi is currently running
Immunotherapy + Targeted Therapy
for Genitourinary Cancers
This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving cabozantinib, nivolumab, and ipilimumab may work better in treating patients with genitourinary tumors that have no treatment options compared to giving cabozantinib, nivolumab, or ipilimumab alone.
Recruiting1 award Phase 221 criteria
Gemcitabine + Cisplatin
for Bladder Cancer
This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading.
Recruiting1 award Phase 2
More about Amir Mortazavi
Clinical Trial Related3 years of experience running clinical trials · Led 8 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Amir Mortazavi has experience with
- Nivolumab
- Ipilimumab
- Cisplatin
- Gemcitabine
- Sitravatinib
- Carboplatin
Breakdown of trials Amir Mortazavi has run
Bladder Cancer
Cancer
Tumors
Transitional Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Amir Mortazavi specialize in?
Amir Mortazavi focuses on Bladder Cancer and Cancer. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage II.
Is Amir Mortazavi currently recruiting for clinical trials?
Yes, Amir Mortazavi is currently recruiting for 2 clinical trials in Columbus Ohio. If you're interested in participating, you should apply.
Are there any treatments that Amir Mortazavi has studied deeply?
Yes, Amir Mortazavi has studied treatments such as Nivolumab, Ipilimumab, Cisplatin.
What is the best way to schedule an appointment with Amir Mortazavi?
Apply for one of the trials that Amir Mortazavi is conducting.
What is the office address of Amir Mortazavi?
The office of Amir Mortazavi is located at: Ohio State University Comprehensive Cancer Center, Columbus, Ohio 43210 United States. This is the address for their practice at the Ohio State University Comprehensive Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.